P4‐099: GASTROINTESTINAL (GI) TRACT MICROBIOME‐MEDIATED UP‐REGULATION OF MICRORNA‐146A IN SPORADIC ALZHEIMER'S DISEASE BRAIN

Yuhai Zhao,Nathan M. Sharfman,Vivian Jaber,Wenhong LI,Walter J. Lukiw

DOI: https://doi.org/10.1016/j.jalz.2019.06.3759

2019-01-01

Abstract:The first definitive indication of a potential molecular-genetic and mechanistic link between the pathobiology of the human gastrointestinal (GI)-tract microbiome and its contribution to the pathogenetic mechanisms of sporadic Alzheimer's disease (AD) came a scant 6 years ago (Bhattacharjee S, Lukiw WJ. Alzheimer's disease and the microbiome. Front Cell Neurosci (2013) 7:153.10.3389/fncel.2013.00153). Ongoing research continues to strengthen the hypothesis that neurotoxic microbial-derived components of the GI tract microbiome (both viral- and bacterial-derived) can cross aging GI tract and blood–brain barriers and contribute to progressive pro-inflammatory neurodegeneration, as exemplified by the AD-process. Analysis, culture and extraction of Bacteroides fragilis, Escherichia coli and other Gram-negative anaerobes; bioinformatic algorithms; collection and culture of human GI tract microbial species; DNA and RNA sequencing; LED-Northern dot blotting; messenger RNA (mRNA) and micro RNA (miRNA) based microfluidic array analysis; quantitative and analytical RT-PCR and imunocytochemistry; viral assay and quantitation of HSV-1. Of central interest in these recent investigations are the pathological roles played by human GI tract resident Gram-negative anaerobic bacteria and neurotropic viruses—two prominent divisions of GI tract microbiome-derived microbiota—which harbor considerable pathogenic potential. It is noteworthy that the first two well-studied microbiota—the GI tract abundant Gram-negative bacteria Bacteroides fragilis and the neurotropic herpes simplex virus-1 (HSV-1) both share a final common pathway of NF-κB (p50/p65) activation and microRNA-146a induction with ensuing pathogenic stimulation of innate-immune and neuroinflammatory pathways. These appear to strongly contribute to the inflammation-mediated amyloidogenic neuropathology of AD. The work in this paper: (i) expands recent research that has extended our understanding of the nature of the translocation of microbiome-derived neurotoxins-across biophysiological barriers; (ii) has assessed the induction of the pro-inflammatory pathogenic microRNA-146a by these two prominent classes of human GI-tract microbiota (B. fragilis and HSV-1); and (iii) advances the role of molecular neurobiology and mechanistic contribution of polymicrobial infections to AD-type neuropathological change.